Show simple item record

dc.contributorR032760X
dc.creatorMaramba, Patience Julia
dc.date.accessioned2017-01-12T06:29:45Z
dc.date.accessioned2019-05-28T14:36:38Z
dc.date.available2017-01-12T06:29:45Z
dc.date.available2019-05-28T14:36:38Z
dc.date.created2017-01-12T06:29:45Z
dc.date.issued2016-11
dc.identifierhttp://hdl.handle.net/10646/2894
dc.identifier.urihttp://zdhr.uz.ac.zw/xmlui/handle/123456789/1260
dc.description.abstractBACKGROUND: The use of HAART has turned HIV/AIDS into a chronic disease and people live longer. They now present with complications related to the treatment, ageing process and the virus itself. Renal dysfunction is a recognized complication in HIV infected patients on HAART and can present as acute kidney injury or chronic kidney disease. METHODS: A cross sectional study was conducted at Parirenyatwa Hospital on patients receiving HAART. Inclusion criteria were age ≥ 18 years and provision of an informed consent. Clinical data was recorded. Body mass index, CD4 count, serum creatinine, urine for dipstick proteinuria and protein: creatinine ratio was collected. Creatinine was calculated using the Cockcroft-Gault formula. Renal dysfunction was defined as Creatinine clearance (CrCl)< 60mL/min. RESULTS: A total of 122 patients with complete data were analysed. 69% were females. Mean age of patients was 37.7 ±11.3 years and Body mass index was26.0 ±5.2 kg/m². Renal dysfunction defined as CrCl< 60mL/min was found in 18.9 %,(n =23/122). Microalbuminuria was found to be a risk factor for renal dysfunction [OR 4.24 95% CI 1.00-17.04] p < 0.049. CONCLUSION: Renal dysfunction is common among patients on HAART and micro albuminuria is a risk factor for developing renal dysfunction. For patients on HAART routine urine protein: creatinine ratio and calculation of creatinine clearance should be done at regular intervals to monitor if the patients are developing renal dysfunction.
dc.languageen_ZW
dc.subjectRenal Dysfunction
dc.subjectRenal Insufficiency
dc.subjectHIV positive patients
dc.titleRenal dysfunction in HIV positive patients on highly active antiretroviral therapy (HAART)


Files in this item

FilesSizeFormatView
Maramba._Renal_ ... iretroviralTherapy_pdf.pdf827.0Kbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record